Novel Combination Approaches to Treat Chemotherapy Refractory Cancer

摘要

The present invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I), a therapeutically effective amount of paclitaxel and a low dose of gemcitabine, and its use in the treatment of a subject having cancer, and kits comprising said composition to provide.